John Wiley & Sons: Osteoporosis Treatment May Also Protect Against Pneumonia
June 03, 2020
June 03, 2020
HOBOKEN, New Jersey, June 3 -- John Wiley and Sons issued the following news release:
A recent study found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia. The results are published in the Journal of Bone and Mineral Research.
The study included 4,041 patients with hip fractures who received N-BPs and 11,802 who did not. . . .
A recent study found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia. The results are published in the Journal of Bone and Mineral Research.
The study included 4,041 patients with hip fractures who received N-BPs and 11,802 who did not. . . .